Xiangliang Yuan Selected Research

Granulocyte Colony-Stimulating Factor (G-CSF)

1/2020

Blocking immunosuppressive neutrophils deters pY696-EZH2-driven brain metastases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiangliang Yuan Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 06/2014
6	Stomach Neoplasms (Stomach Cancer) 11/2020 - 08/2016
4	Neoplasm Metastasis (Metastasis) 01/2020 - 06/2013
2	Colorectal Neoplasms (Colorectal Cancer) 07/2017 - 06/2015
2	Inflammation (Inflammations) 02/2015 - 10/2012
2	Hepatitis B 10/2013 - 01/2013
1	Cryopyrin-Associated Periodic Syndromes 12/2023
1	Hypersensitivity (Allergy) 10/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2020
1	Colitis 01/2019
1	Stomach Diseases 10/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2015
1	Leukemia 02/2015
1	HIV Infections (HIV Infection) 02/2014
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2013
1	Paraproteinemias (Monoclonal Gammopathy) 01/2013
1	Multiple Myeloma 01/2013
1	Acute Coronary Syndrome 10/2012

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2016
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
3	B7-H1 AntigenIBA 11/2020 - 10/2017
2	ApolipoproteinsIBA 01/2023 - 01/2018
2	Apolipoproteins E (ApoE)IBA 01/2023 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 06/2013
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 07/2017
2	Formaldehyde (Formol)FDA Link 10/2017 - 06/2015
2	ParaffinIBA 10/2017 - 06/2015
2	Activating Transcription Factor 3IBA 07/2017 - 06/2013
2	GelsolinIBA 08/2016 - 06/2013
1	InflammasomesIBA 12/2023
1	Adenosine Triphosphatases (ATPase)IBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	LigandsIBA 01/2023
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2022
1	Histamine Receptors (Histamine Receptor)IBA 10/2022
1	Histamine Antagonists (Antihistamines)IBA 10/2022
1	purineIBA 01/2022
1	Inosine FDA Link 01/2022
1	Vitamin E FDA LinkGeneric 01/2022
1	Protein Tyrosine PhosphatasesIBA 01/2022
1	Tamoxifen FDA LinkGeneric 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2021
1	Aromatase InhibitorsIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 11/2020
1	LipidsIBA 11/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2020
1	CateninsIBA 01/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	MethyltransferasesIBA 01/2020
1	KinesinsIBA 01/2020
1	Blocking AntibodiesIBA 01/2020
1	CytokinesIBA 01/2020
1	IpilimumabIBA 01/2019
1	NivolumabIBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	ChromatinIBA 07/2017
1	RNA (Ribonucleic Acid)IBA 07/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Antiviral Agents (Antivirals)IBA 02/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2015
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 06/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2014
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2014
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2013
1	Hepatitis B e AntigensIBA 10/2013
1	B-Cell Activating FactorIBA 01/2013
1	ParaproteinsIBA 01/2013
1	Interleukin-17 (Interleukin 17)IBA 10/2012
1	OsteopontinIBA 10/2012

Therapy/Procedure

7	Immunotherapy 01/2023 - 01/2018
7	Therapeutics 01/2022 - 02/2015
1	Drug Therapy (Chemotherapy) 01/2017
1	Microspheres (Microsphere) 10/2013
1	Lasers (Laser) 10/2013
1	Quantum Dots (Quantum Dot) 01/2013